NEW YORK, NEW YORK, UNITED STATES, November 23, 2023 / EINPresswire.com / -- CD BioSciences recently announced the launch of its bio-layer interferometry (BLI) platform. This platform aims to ...

With over 60,000 publications in 2022 and over two thirds of all papers on the topic published in the last five years, nanoparticles are a top focus in research and development labs, across the globe.

There are currently 35 monoclonal antibodies approved by the FDA as biotherapeutic agents, representing the most rapidly growing class of new drugs. Despite advances in downstream processing ...

Researchers need to know how biomolecules interact with one another, both for studying biological mechanisms and developing new therapeutic agents. One way to do this is to attach labels onto ...